# Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites

> **NCT00265863** · PHASE2 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 1 (actual)

## Conditions studied

- Metastatic Cancer

## Interventions

- **DRUG:** mitomycin C

## Key facts

- **NCT ID:** NCT00265863
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-08
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Withdrawn due to slow accrual
- **Last updated:** 2017-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00265863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00265863, "Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00265863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*